J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodriguez, D.
Right arrow Articles by del Real, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, D.
Right arrow Articles by del Real, G.
Agricola
Right arrow Articles by Rodriguez, D.
Right arrow Articles by del Real, G.

Journal of General Virology, Vol 80, 217-223, Copyright © 1999 by Society for General Microbiology

ARTICLES

A human immunodeficiency virus type 1 Env-granulocyte-macrophage colony- stimulating factor fusion protein enhances the cellular immune response to Env in a vaccinia virus-based vaccine

D Rodriguez, JR Rodriguez, M Llorente, I Vazquez, P Lucas, M Esteban, C Martinez-A and G del Real
Department of Molecular & Cellular Biology, Centro Nacional de Biotecnologia, CSIC/UAM, Madrid, Spain.

Vaccinia virus (VV) infection induces protective T- and B-cell responses, making recombinants based on VV good candidates for the development of effective vaccines to other viruses. VV recombinants expressing the human immunodeficiency virus (HIV) envelope protein (Env) have been generated in several laboratories and shown to induce anti-HIV cellular and humoral immune responses in vaccinated humans and in chimpanzees. To increase the immunogenicity of the Env antigen, a VV recombinant was generated that expresses a chimeric antigen consisting of the Env protein fused to an immunostimulatory cytokine, granulocyte- macrophage colony-stimulating factor (GM-CSF). The chimeric protein retained GM-CSF biological activity when expressed by this recombinant virus (VV-GM-gp120) in cells infected in vitro. Infection of BALB/c mice with VV-GM-gp120 triggered a higher HIV-specific cellular immune response, as measured by interferon-gamma production, than that induced by a VV recombinant expressing the native Env protein. Moreover, although anti-gp120 antibody titres were similar in sera from mice inoculated with either of the VV recombinants, immunization with the recombinant expressing the fusion protein elicited antibodies against a broader spectrum of Env epitopes. These results indicate that HIV Env antigen fusion to GM-CSF provides a means to improve the anti-HIV immune response.


This article has been cited by other articles:


Home page
 J. Gen. Virol.Home page
M. M. Gherardi and M. Esteban
Recombinant poxviruses as mucosal vaccine vectors
J. Gen. Virol., November 1, 2005; 86(11): 2925 - 2936.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. K. Singh and M. A. Barry
Repertoire and Immunofocusing of CD8 T Cell Responses Generated by HIV-1 gag-pol and Expression Library Immunization Vaccines
J. Immunol., October 1, 2004; 173(7): 4387 - 4393.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1999 by the Society for General Microbiology.